Ultrasound‐Responsive 4D Bioscaffold for Synergistic Sonopiezoelectric‐Gaseous Osteosarcoma Therapy and Enhanced Bone Regeneration
Advanced Science · 2025
DOI: 10.1002/advs.202417208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Haoyu Fang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, …. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Regeneration, Bone Neoplasms, Ultrasonic Therapy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Various antitumor strategies have emerged to address the escalating need for effective tumor eradication. However, achieving precise and spatiotemporally controlled dynamic therapies remains promising yet challenging. Sonopiezoelectric nanotherapy eliminates tumor cells by generating reactive oxygen species (ROS) through ultrasound stimulation, enabling spatiotemporal control and ensuring safety during deep tissue penetration. In this study, a hybrid bioscaffold incorporating few‐layer black phosphorus (BP) and nitric oxide (NO) donors are rationally designed and engineered for sonopiezoelectric‐gaseous synergistic therapy. This ultrasound‐responsive system provides a stepwise countermeasure against tumor invasion in bone tissues. Ultrasonic vibration induces mechanical strain in BP nanosheets, leading to piezoelectric polarization and subsequent ROS generation. Moreover, ultrasound‐triggered NO burst release from the donors enables spatiotemporally controlled gas therapy. The synergistic effects of sonopiezoelectric therapy and ultrasound‐excited gas therapy enhance tumor eradication, effectively inhibiting tumor proliferation and metastasis while minimizing off‐target cytotoxicity. Additionally, the biomineralization capability of degradable BP and proangiogenic effects of low‐concentration NO establish the hybrid bioscaffold as a bioactive platform that facilitates subsequent bone regeneration. The development of this 4D multifunctional therapeutic platform, characterized by superior sonopiezoelectric efficacy, controlled NO release, and stimulatory effects on tissue regeneration, offers new insights into the comprehensive treatment of invasive bone tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
- Laboratory Center, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China.
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, China.
ORCID-Profile: Haoyu Fang, Youshui Gao
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Fang, H., Zhu, D., Chen, Y., Zhang, C., Li, G., Fang, Q., Chang, M., Chen, Y., & Gao, Y. (2025). Ultrasound‐Responsive 4D Bioscaffold for Synergistic Sonopiezoelectric‐Gaseous Osteosarcoma Therapy and Enhanced Bone Regeneration. Advanced Science. https://doi.org/10.1002/advs.202417208
Vancouver
Fang H, Zhu D, Chen Y, Zhang C, Li G, Fang Q, et al. Ultrasound‐Responsive 4D Bioscaffold for Synergistic Sonopiezoelectric‐Gaseous Osteosarcoma Therapy and Enhanced Bone Regeneration. Advanced Science. 2025. doi:10.1002/advs.202417208
BibTeX
@article{Fang2025,
author = {Fang, Haoyu and Zhu, Daoyu and Chen, Yixuan and Zhang, Changqing and Li, Gan and Fang, Qihang and Chang, Meiqi and Chen, Yu and Gao, Youshui},
title = {Ultrasound‐Responsive 4D Bioscaffold for Synergistic Sonopiezoelectric‐Gaseous Osteosarcoma Therapy and Enhanced Bone Regeneration},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202417208}
}
EUVIMED